精氨酰-甘氨酰-天冬氨酸 Arg-Gly-Asp 99896-85-2

價(jià)格	詢價(jià)
包裝	20mg	5mg	100mg

最小起訂量	20mg
發(fā)貨地	四川
更新日期	2024-12-19

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:精氨酰-甘氨酰-天冬氨酸	英文名稱:Arg-Gly-Asp
CAS:99896-85-2	品牌: 維克奇
產(chǎn)地: 成都	保存條件: -20℃，干燥、避光、密封
純度規(guī)格: HPLC≥98%	產(chǎn)品類別: 標(biāo)準(zhǔn)品

WKQ-0014170

中文名稱：精氨酰-甘氨酰-天冬氨酸

英文名稱：Arg-Gly-Asp

英文別名：L-Aspartic acid, N-(N-L-arginylglycyl)-;L-Arginylglycyl-L-aspartic acid;101: PN: WO2015160770 PAGE: 103 claimed protein;10: PN: JP2003189848 PAGE: 2 claimed protein;10: PN: WO2004013310 PAGE: 14 claimed protein;10: PN: WO2010125722 SEQID: 1 unclaimed protein;11: PN: WO2012061443 SEQID: 9 unclaimed protein;129: PN: US20110166072 SEQID: 2 unclaimed protein;12: PN: EP2343081 PAGE: 9 claimed protein;12: PN: FR2936247 PAGE: 26 claimed protein;12: PN: WO2010034718 PAGE: 27 claimed protein;1337: PN: US20090258017 SEQID: 1353 claimed protein;1338: PN: WO2007124090 SEQID: 1353 claimed protein;13: PN: US6147189 SEQID: 1 claimed protein;15: PN: EP3415165 SEQID: 15 claimed protein;15: PN: US20180237740 SEQID: 15 claimed protein;16: PN: WO2012103361 SEQID: 16 unclaimed protein;18: PN: WO2021133142 SEQID: 18 claimed protein;18: PN: WO2021133143 SEQID: 18 claimed protein;1: PN: CN101264330 PAGE: 2 claimed protein;1: PN: CN112794917 SEQID: 1 claimed protein;1: PN: EP2455104 SEQID: 3 claimed protein;1: PN: JP2009072081 PAGE: 7 claimed protein;1: PN: JP2011160854 PAGE: 2 claimed protein;1: PN: JP2017085919 PAGE: 2 claimed sequence;1: PN: JP2022042061 PAGE: 2 claimed sequence;1: PN: KR20150027940 SEQID: 1 claimed protein;1: PN: KR20150126567 PAGE: 3 claimed sequence;1: PN: KR20160026441 SEQID: 16 claimed sequence;1: PN: KR20170136178 PAGE: 3 claimed sequence;1: PN: RU2543651 PAGE: 6 claimed sequence;1: PN: US20080262614 SEQID: 1 unclaimed protein;1: PN: US20100099190 PAGE: 9 claimed protein;1: PN: US20110217365 PAGE: 47 claimed protein;1: PN: US20160271151 PAGE: 15 claimed sequence;1: PN: US20160355780 SEQID: 15 claimed sequence;1: PN: US20200370021 SEQID: 15 claimed protein;1: PN: US6084066 SEQID: 1 claimed protein;1: PN: WO0004941 PAGE: 31 claimed protein;1: PN: WO0045856 PAGE: 199 claimed protein;1: PN: WO0147553 PAGE: 13 claimed protein;1: PN: WO03084980 SEQID: 5 claimed protein;1: PN: WO2005027990 SEQID: 1 claimed protein;1: PN: WO2008150101 SEQID: 1 claimed protein;1: PN: WO2010093333 PAGE: 19 unclaimed protein;1: PN: WO2010094085 SEQID: 1 unclaimed protein;1: PN: WO2010101627 PAGE: 108 claimed protein;1: PN: WO2010151159 PAGE: 33 claimed protein;1: PN: WO2012060351 SEQID: 1 claimed protein;1: PN: WO2012065751 SEQID: 3 claimed protein;1: PN: WO2013007839 PAGE: 96 claimed protein;1: PN: WO2020018418 PAGE: 17 claimed sequence;1: PN: WO2021096303 SEQID: 1 claimed protein;1: PN: WO2021123799 SEQID: 1 claimed protein;1: PN: WO2022027020 PAGE: 57 claimed sequence;21: PN: WO2010050903 SEQID: 17 unclaimed protein;227: PN: WO2021146455 SEQID: 300 claimed protein;23: PN: WO03070749 PAGE: 36 claimed protein;24: PN: US6797807 PAGE: 59-60 claimed protein;24: PN: WO2013001819 SEQID: 1 unclaimed protein;25: PN: WO2011066511 SEQID: 25 unclaimed protein;2: PN: IL247369 SEQID: 6 claimed protein;2: PN: JP2003038633 PAGE: 1 claimed protein;2: PN: JP2004344469 SEQID: 2 claimed protein;2: PN: SG10201703850 PAGE: 27 claimed sequence;2: PN: US20030113478 SEQID: 2 claimed protein;2: PN: US20060233855 SEQID: 1 claimed protein;2: PN: WO2004058305 PAGE: 39 claimed protein;2: PN: WO2008124834 PAGE: 26 claimed protein;2: PN: WO2009019685 PAGE: 12 claimed protein;2: PN: WO2012146729 PAGE: 33 claimed protein;2: PN: WO2017078439 PAGE: 17 claimed sequence;2: PN: WO2018033928 SEQID: 6 claimed protein;2: PN: WO2019046943 PAGE: 47 claimed sequence;35: PN: US20110287045 SEQID: 2 claimed protein;3: PN: CN110804100 SEQID: 3 claimed protein;3: PN: JP2002369878 PAGE: 2 claimed protein;3: PN: US20200239521 SEQID: 5 claimed sequence;3: PN: US6521211 PAGE: 151 claimed protein;3: PN: WO2014025890 SEQID: 3 claimed protein;3: PN: WO2021021930 SEQID: 3 claimed sequence;44: PN: US20190192738 PAGE: 22 claimed sequence;47: PN: WO2011081523 PAGE: 36 claimed protein;47: PN: WO2011081523 PAGE: 36 claimed sequence;49: PN: US6465427 PAGE: 134 claimed protein;4: PN: KR20120134276 SEQID: 5 claimed protein;4: PN: KR20180024581 SEQID: 4 claimed sequence;4: PN: WO0147549 PAGE: 19 claimed protein;4: PN: WO2004071545 PAGE: 20 claimed protein;4: PN: WO2007030469 PAGE: 47 claimed protein;4: PN: WO2018044012 SEQID: 4 claimed protein;4: PN: WO2020014106 SEQID: 23 claimed sequence;4: PN: WO2020019022 PAGE: 45 claimed sequence;4: PN: WO2020097235 SEQID: 30 claimed protein;503: PN: WO0183525 TABLE: 9 claimed protein;50: PN: WO2014042463 SEQID: 51 unclaimed protein;51: PN: WO03027151 PAGE: 64 claimed protein;52: PN: US20200222518 SEQID: 52 claimed protein;52: PN: WO2018237010 SEQID: 52 claimed protein;5: PN: JP2012126720 SEQID: 5 unclaimed protein;5: PN: US20180243419 PAGE: 16 claimed protein;5: PN: WO2013055905 SEQID: 5 unclaimed protein;61: PN: WO2009129263 SEQID: 48 unclaimed protein;68: PN: WO2005118642 SEQID: 147 claimed protein;6: PN: CN107629114 SEQID: 17 claimed sequence;6: PN: KR20090132815 PAGE: 3 claimed protein;6: PN: KR20090132911 SEQID: 101 claimed protein;6: PN: WO2012153616 SEQID: 5 unclaimed protein;6: PN: WO2020079303 SEQID: 9 claimed protein;70: PN: WO03072542 SEQID: 75 claimed protein;73: PN: WO03044045 SEQID: 74 claimed protein;7: PN: CN105079780 SEQID: 7 claimed sequence;7: PN: CN106063928 SEQID: 7 claimed sequence;7: PN: US20130052712 SEQID: 8 claimed protein;81: PN: US6001965 SEQID: 81 claimed protein;8: PN: KR20120114072 SEQID: 8 claimed protein;8: PN: KR20160113372 SEQID: 8 claimed sequence;8: PN: KR20160129982 SEQID: 8 claimed sequence;8: PN: WO2010054316 SEQID: 8 unclaimed protein;8: PN: WO2011025158 SEQID: 8 claimed protein;9: PN: CN104740605 SEQID: 9 claimed protein;9: PN: US20030211141 SEQID: 9 unclaimed protein;Arg-Gly-Asp;Arginine-glycine-aspartic acid;Arginylglycylaspartic acid;RGD;RGD peptide;Tripeptides, RGD;arginine-glycine-aspartatic acid (RGD) peptide;

分子式：C12H22N6O6

分子量：346.34

CAS號(hào)：99896-85-2

純度：HPLC≥98%

熔點(diǎn)：153-155 °C | Condition: Solv: ethyl ether (60-29-7)

密度：1.61±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度數(shù)：2.85±0.10 | Condition: Most Acidic Temp: 25 °C

儲(chǔ)存條件：-20℃，干燥、避光、密封

規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝

供應(yīng)單位：四川省維克奇生物科技有限公司

供應(yīng)電話：028-81700200/4008005713

四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！新批次有現(xiàn)貨，歡迎咨詢。

關(guān)鍵字： 99896-85-2;

公司簡(jiǎn)介

成都彼樣生物科技有限公司是四川省成都市一家專業(yè)從事天然藥物純化分離，集生產(chǎn)研發(fā)/銷售于一體的公司。公司名下有四家公司“成都標(biāo)樣生物科技有限公司，成都超九八生物科技有限公司，四川省維克奇生物科技有限公司”。　　2014年我公司與中國(guó)科學(xué)院成都生物研究所共建聯(lián)合實(shí)驗(yàn)室，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。實(shí)驗(yàn)室擁有一批精密的分離純化系統(tǒng)和檢測(cè)設(shè)備;擁有一批技術(shù)精湛的研究隊(duì)伍;擁有一套完整的質(zhì)量管理體系; 　　公司可承接以下業(yè)務(wù)：　　1、指定化合物克級(jí)---公斤級(jí)定制業(yè)務(wù); 　　2、指定藥材全系列的分離純化業(yè)務(wù); 　　3、新化合物的分離純化及結(jié)構(gòu)鑒定業(yè)務(wù); 　　4、指

成立日期	2016-09-09 （9年）	注冊(cè)資本	100000
員工人數(shù)	10-50人	年?duì)I業(yè)額	￥ 100萬(wàn)-300萬(wàn)
主營(yíng)行業(yè)	化學(xué)試劑,高純?cè)噭?/td>	經(jīng)營(yíng)模式	試劑

成都彼樣生物科技有限公司

VIP 6年

公司成立：9年
注冊(cè)資本：100000
企業(yè)類型：有限責(zé)任公司
主營(yíng)產(chǎn)品：甘草系列、人參系列、補(bǔ)骨脂系列、雷公藤系列、銀杏系列、黃芪皂苷系列、黃芩系列、柴胡系列、酸棗仁系列、重樓系列、五味子系列、大黃系列、丹參系列、柴胡系列、遠(yuǎn)志系列、平貝系列等
公司地址：青羊區(qū)日月大道一段978號(hào)青羊萬(wàn)達(dá)3幢1單元1632

進(jìn)入店鋪

詢盤

店內(nèi)推薦

317331-27-4

詢價(jià)

96426-21-0

詢價(jià)

Arg-Gly-Asp-Ser 91037-65-9

詢價(jià)